These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25617044)

  • 1. Are CXCL13/CXCR5/FAK critical regulators of MSCs migration and differentiation?
    Zhang Y; Ma C; Yu Y; Liu M; Yi C
    Med Hypotheses; 2015 Mar; 84(3):213-5. PubMed ID: 25617044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR5-Overexpressing Mesenchymal Stromal Cells Exhibit Enhanced Homing and Can Decrease Contact Hypersensitivity.
    Zhang X; Huang W; Chen X; Lian Y; Wang J; Cai C; Huang L; Wang T; Ren J; Xiang AP
    Mol Ther; 2017 Jun; 25(6):1434-1447. PubMed ID: 28454789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.
    Del Grosso F; Coco S; Scaruffi P; Stigliani S; Valdora F; Benelli R; Salvi S; Boccardo S; Truini M; Croce M; Ferrini S; Longo L; Tonini GP
    Mol Cancer Res; 2011 Jul; 9(7):815-23. PubMed ID: 21642390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
    Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
    Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.
    El Haibi CP; Sharma PK; Singh R; Johnson PR; Suttles J; Singh S; Lillard JW
    Mol Cancer; 2010 Apr; 9():85. PubMed ID: 20412587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis.
    Müller I; Vaegler M; Holzwarth C; Tzaribatchev N; Pfister SM; Schütt B; Reize P; Greil J; Handgretinger R; Rudert M
    Leukemia; 2008 Nov; 22(11):2054-61. PubMed ID: 18719618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer.
    Qi XW; Xia SH; Yin Y; Jin LF; Pu Y; Hua D; Wu HR
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1916-24. PubMed ID: 25010623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma.
    Liu JF; Lee CW; Lin CY; Chao CC; Chang TM; Han CK; Huang YL; Fong YC; Tang CH
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
    Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
    J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL13/CXCR5 signaling axis in cancer.
    Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
    Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
    Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
    FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
    Halvorsen B; Smedbakken LM; Michelsen AE; Skjelland M; Bjerkeli V; Sagen EL; Taskén K; Bendz B; Gullestad L; Holm S; Biessen EA; Aukrust P
    Atherosclerosis; 2014 Jun; 234(2):352-9. PubMed ID: 24732574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR5 overexpression in HL-60 cells enhances chemotaxis toward CXCL13 without anticipated interaction partners or enhanced MAPK signaling.
    MacDonald RJ; Yen A
    In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):725-735. PubMed ID: 30276608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical stretch upregulates SDF-1α in skin tissue and induces migration of circulating bone marrow-derived stem cells into the expanded skin.
    Zhou SB; Wang J; Chiang CA; Sheng LL; Li QF
    Stem Cells; 2013 Dec; 31(12):2703-13. PubMed ID: 23836581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF Enhances the Migration of MSCs in Neural Differentiation by Regulating Focal Adhesion Turnover.
    Wang H; Wang X; Qu J; Yue Q; Hu Y; Zhang H
    J Cell Physiol; 2015 Nov; 230(11):2728-42. PubMed ID: 25820249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.
    Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Ransohoff RM; Ness JM; Colliver JA
    J Neuroimmunol; 2012 Feb; 243(1-2):81-8. PubMed ID: 22264765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL13 promotes the effect of bone marrow mesenchymal stem cells (MSCs) on tendon-bone healing in rats and in C3HIOT1/2 cells.
    Tian F; Ji XL; Xiao WA; Wang B; Wang F
    Int J Mol Sci; 2015 Jan; 16(2):3178-87. PubMed ID: 25647417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54.
    Lisignoli G; Cristino S; Piacentini A; Cavallo C; Caplan AI; Facchini A
    J Cell Physiol; 2006 May; 207(2):364-73. PubMed ID: 16331675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.